FDA recognizes MITA for pediatric dose reduction efforts

The Medical Imaging & Technology Alliance (MITA) has received the FDA’s “Leveraging/Collaboration Award” for developing a collaborative network aimed at reducing unnecessary radiation exposure from imaging exams to pediatric patients.

In addition to ongoing collaboration with the FDA, MITA has partnered with the Alliance for Radiation Safety in Pediatric Imaging and its “Image Gently” campaign to educate medical professionals and parents about imaging protocols that can reduce imaging-related dose for children. In 2010, MITA published the CT Dose Check Standard, which included dose notifications and dose alerts.

MITA will be formally recognized on June 18 for its dedication to excellence in accomplishing the mission of the FDA’s Center for Devices and Radiology Health.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.